Virtual patient 3D dose reconstruction using in air EPID measurements and a back-projection algorithm for IMRT and VMAT treatments.

PURPOSE At our institute, a transit back-projection algorithm is used clinically to reconstruct in vivo patient and in phantom 3D dose distributions using EPID measurements behind a patient or a polystyrene slab phantom, respectively. In this study, an extension to this algorithm is presented whereby in air EPID measurements are used in combination with CT data to reconstruct 'virtual' 3D dose distributions. By combining virtual and in vivo patient verification data for the same treatment, patient-related errors can be separated from machine, planning and model errors. METHODS AND MATERIALS The virtual back-projection algorithm is described and verified against the transit algorithm with measurements made behind a slab phantom, against dose measurements made with an ionization chamber and with the OCTAVIUS 4D system, as well as against TPS patient data. Virtual and in vivo patient dose verification results are also compared. RESULTS Virtual dose reconstructions agree within 1% with ionization chamber measurements. The average γ-pass rate values (3% global dose/3mm) in the 3D dose comparison with the OCTAVIUS 4D system and the TPS patient data are 98.5±1.9%(1SD) and 97.1±2.9%(1SD), respectively. For virtual patient dose reconstructions, the differences with the TPS in median dose to the PTV remain within 4%. CONCLUSIONS Virtual patient dose reconstruction makes pre-treatment verification based on deviations of DVH parameters feasible and eliminates the need for phantom positioning and re-planning. Virtual patient dose reconstructions have additional value in the inspection of in vivo deviations, particularly in situations where CBCT data is not available (or not conclusive).

[1]  J J Sonke,et al.  Dose-response and ghosting effects of an amorphous silicon electronic portal imaging device. , 2003, Medical physics.

[2]  Laure Vieillevigne,et al.  Gamma index comparison of three VMAT QA systems and evaluation of their sensitivity to delivery errors. , 2015, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

[3]  Maarten L P Dirkx,et al.  Dosimetric pre-treatment verification of IMRT using an EPID; clinical experience. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[4]  Jan-Jakob Sonke,et al.  In aqua vivo EPID dosimetry. , 2011, Medical physics.

[5]  J. Dempsey,et al.  Evaluation of the gamma dose distribution comparison method. , 2003, Medical physics.

[6]  Nilendu Gupta,et al.  Commissioning and comprehensive evaluation of the ArcCHECK cylindrical diode array for VMAT pretreatment delivery QA , 2014, Journal of applied clinical medical physics.

[7]  Todd Pawlicki,et al.  Statistical process control analysis for patient-specific IMRT and VMAT QA , 2012, Journal of radiation research.

[8]  Jan-Jakob Sonke,et al.  Simplifying EPID dosimetry for IMRT treatment verification. , 2011, Medical physics.

[9]  Harish K. Malhotra,et al.  EPID dosimetry for pretreatment quality assurance with two commercial systems , 2012, Journal of applied clinical medical physics.

[10]  Benjamin E Nelms,et al.  Moving from gamma passing rates to patient DVH-based QA metrics in pretreatment dose QA. , 2011, Medical physics.

[11]  Niko Papanikolaou,et al.  Evaluation of Dosimetry Check software for IMRT patient‐specific quality assurance , 2015, Journal of applied clinical medical physics.

[12]  Xiaowu Deng,et al.  Fast 3D dosimetric verifications based on an electronic portal imaging device using a GPU calculation engine , 2015, Radiation Oncology.

[13]  Philippe Lambin,et al.  The next step in patient-specific QA: 3D dose verification of conformal and intensity-modulated RT based on EPID dosimetry and Monte Carlo dose calculations. , 2008, Radiotherapy and Oncology.

[14]  David S Followill,et al.  Institutional patient-specific IMRT QA does not predict unacceptable plan delivery. , 2014, International journal of radiation oncology, biology, physics.

[15]  Wolfgang A. Tomé,et al.  Evaluation of a fast method of EPID‐based dosimetry for intensity‐modulated radiation therapy , 2010, Journal of applied clinical medical physics.

[16]  Suman Mallik,et al.  Portal dosimetry for pretreatment verification of IMRT plan: a comparison with 2D ion chamber array , 2010, Journal of applied clinical medical physics.

[17]  Marcel van Herk,et al.  Overview of 3-year experience with large-scale electronic portal imaging device-based 3-dimensional transit dosimetry. , 2015, Practical radiation oncology.

[18]  M. Kathirvel,et al.  Pretreatment quality assurance of volumetric modulated arc therapy on patient CT scan using indirect 3D dosimetry system , 2014 .

[19]  Lei Xing,et al.  American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guidelines for image-guided radiation therapy (IGRT). , 2010, International journal of radiation oncology, biology, physics.

[20]  Francesco C Stingo,et al.  Toward optimizing patient-specific IMRT QA techniques in the accurate detection of dosimetrically acceptable and unacceptable patient plans. , 2014, Medical physics.

[21]  Jan-Jakob Sonke,et al.  A simple backprojection algorithm for 3D in vivo EPID dosimetry of IMRT treatments. , 2009, Medical physics.

[22]  J. Mechalakos,et al.  IMRT commissioning: multiple institution planning and dosimetry comparisons, a report from AAPM Task Group 119. , 2009, Medical physics.

[23]  D. Low,et al.  A technique for the quantitative evaluation of dose distributions. , 1998, Medical physics.

[24]  Sara Bresciani,et al.  Pretreatment patient-specific IMRT quality assurance: a correlation study between gamma index and patient clinical dose volume histogram. , 2012, Medical physics.

[25]  Xiance Jin,et al.  Correlation between gamma index passing rate and clinical dosimetric difference for pre-treatment 2D and 3D volumetric modulated arc therapy dosimetric verification. , 2015, The British journal of radiology.

[26]  Benjamin E Nelms,et al.  Per-beam, planar IMRT QA passing rates do not predict clinically relevant patient dose errors. , 2011, Medical physics.

[27]  Geoffrey S Ibbott,et al.  American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) Practice Guidelines for Intensity-Modulated Radiation Therapy (IMRT). , 2009, International journal of radiation oncology, biology, physics.

[28]  M. Bucciolini,et al.  Pretreatment verification of IMRT absolute dose distributions using a commercial a-Si EPID. , 2006, Medical physics.

[29]  M. V. van Herk,et al.  Accurate two-dimensional IMRT verification using a back-projection EPID dosimetry method. , 2006, Medical physics.

[30]  W Ansbacher,et al.  Three-dimensional portal image-based dose reconstruction in a virtual phantom for rapid evaluation of IMRT plans. , 2006, Medical physics.

[31]  Cedric X. Yu,et al.  A dose delivery verification method for conventional and intensity-modulated radiation therapy using measured field fluence distributions. , 2003, Medical physics.

[32]  B. Heijmen,et al.  3D dose reconstruction for clinical evaluation of IMRT pretreatment verification with an EPID. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[33]  Sharon C Dutton,et al.  On using 3D γ-analysis for IMRT and VMAT pretreatment plan QA. , 2012, Medical physics.

[34]  Jan-Jakob Sonke,et al.  3D Dosimetric verification of volumetric-modulated arc therapy by portal dosimetry. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[35]  Jan-Jakob Sonke,et al.  A fast algorithm for gamma evaluation in 3D. , 2007, Medical physics.

[36]  Linda Hong,et al.  Application of AAPM TG 119 to volumetric arc therapy (VMAT) , 2012, Journal of applied clinical medical physics.